栄研化学(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4549/E00961 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2022/05/06 | 日証協 | 293,132株 | -4.5% | 39,400株 | -35.71% | 346,759株 | -10.38% | 42,620株 | -2.02% |
2022/04/28 | 日証協 | 306,934株 | -10.73% | 61,285株 | -47.57% | 386,910株 | -6.3% | 43,500株 | -48.46% |
2022/04/22 | 日証協 | 343,834株 | +7.54% | 116,900株 | -34.51% | 412,930株 | +5.87% | 84,402株 | -8.75% |
2022/04/15 | 日証協 | 319,730株 | +10.97% | 178,496株 | -3.56% | 390,024株 | +16.08% | 92,500株 | -36.54% |
2022/04/08 | 日証協 | 288,119株 | -2.11% | 185,083株 | +129.06% | 335,991株 | -20.44% | 145,765株 | +14.99% |
2022/04/01 | 日証協 | 294,319株 | -23.18% | 80,800株 | -74.33% | 422,291株 | -20.47% | 126,768株 | +4.5% |
2022/03/25 | 日証協 | 383,124株 | +14.25% | 314,743株 | +98.57% | 530,990株 | +1.87% | 121,313株 | +20.55% |
2022/03/18 | 日証協 | 335,325株 | -3.54% | 158,506株 | -32.51% | 521,260株 | -1.34% | 100,629株 | +11.09% |
2022/03/11 | 日証協 | 347,625株 | +12.31% | 234,852株 | +0.76% | 528,331株 | +6.11% | 90,585株 | +73.59% |
2022/03/04 | 日証協 | 309,525株 | -13.88% | 233,083株 | +61.07% | 497,929株 | -10.3% | 52,182株 | -57.72% |
2022/02/25 | 日証協 | 359,425株 | -10.35% | 144,711株 | -70.96% | 555,128株 | -30.05% | 123,426株 | -50.15% |
2022/02/18 | 日証協 | 400,925株 | -14.52% | 498,349株 | +109.81% | 793,613株 | +9.65% | 247,616株 | +276.75% |
2022/02/10 | 日証協 | 469,014株 | +6.6% | 237,524株 | -30.84% | 723,745株 | +1.68% | 65,724株 | -34.62% |
2022/02/04 | 日証協 | 439,958株 | -9.86% | 343,422株 | +48.6% | 711,760株 | -9.9% | 100,525株 | +58.59% |
2022/01/28 | 日証協 | 488,073株 | +1.39% | 231,106株 | -28.61% | 789,959株 | +2.61% | 63,385株 | -56.78% |
2022/01/21 | 日証協 | 481,373株 | +22.6% | 323,734株 | +30.22% | 769,830株 | +12.42% | 146,671株 | +38.63% |
2022/01/14 | 日証協 | 392,623株 | +9.97% | 248,600株 | +13.9% | 684,759株 | +15.35% | 105,800株 | +35.25% |
2022/01/07 | 日証協 | 357,023株 | +4.25% | 218,260株 | -2.44% | 593,659株 | +1.51% | 78,226株 | +7.3% |
2021/12/30 | 日証協 | 342,475株 | 0% | 223,728株 | 0% | 584,821株 | 0% | 72,901株 | 0% |
※株式分割は考慮していませんのでご注意ください。
Page Top